Abstract
The data from our 1968-69 influenza vaccine field trials are anlaysed and pre-challenge haemagglutinin and neuraminidase serum antibodies are evaluated as indices of protection. Prevention of flu-like disease, fever, confinement to bed, and/or seroconversion to Hong Kong was significantly related to post-vaccine A/Hong Kong/68(H3N2) haemagglutination-inhibition (HI) titres. Prevention of disease was also related, although not significantly statistically in every category, to pre-challenge A/Hong Kong/68 neuraminidase inhibition (NI) titres. The trend was the same regardless of whether the origin of the NI antibody was through A/Aichi/68 or A/Japan/62 vaccines or through pre-Hong Kong influenza infections. In summarizing the data using fever as an index of disease, the attack rate (AR) among volunteers without Hong Kong NI or HI antibody was 45%. Presence of NI antibody, in the absence of HI antibody, significantly reduced the AR to 24%. Those with both NI and HI titres experienced a still lower AR of 14%. Those with HI and NI titres both > 1: 160 ran little risk of disease, with an AR of 7%.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Allan W. H., Madeley C. R., Kendal A. P. Studies with avian influenza A viruses: cross protection experiments in chickens. J Gen Virol. 1971 Aug;12(2):79–84. doi: 10.1099/0022-1317-12-2-79. [DOI] [PubMed] [Google Scholar]
- Edmondson W. P., Jr, Rothenberg R., White P. W., Gwaltney J. M., Jr A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol. 1971 Jun;93(6):480–486. doi: 10.1093/oxfordjournals.aje.a121282. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hierholzer J. C., Suggs M. T., Hall E. C. Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation. Appl Microbiol. 1969 Nov;18(5):824–833. doi: 10.1128/am.18.5.824-833.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mostow S. R., Schoenbaum S. C., Dowdle W. R., Coleman M. T., Kaye H. S. Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses. Bull World Health Organ. 1969;41(3):525–530. [PMC free article] [PubMed] [Google Scholar]
- RAPMUND G., JOHNSON R. T., BANKHEAD A. S., HERMAN Y. F., DANDRIDGE O. W. The diagnosis of Asian influenza virus infection after recent immunization. U S Armed Forces Med J. 1959 Jun;10(6):637–649. [PubMed] [Google Scholar]
- Schoenbaum S. C., Mostow S. R., Dowdle W. R., Coleman M. T., Kaye H. S. Studies with inactivated influenza vaccines purified by zonal centrifugation. 2. Efficacy. Bull World Health Organ. 1969;41(3):531–535. [PMC free article] [PubMed] [Google Scholar]
- Schulman J. L., Khakpour M., Kilbourne E. D. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol. 1968 Aug;2(8):778–786. doi: 10.1128/jvi.2.8.778-786.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Webster R. G., Pereira H. G. A common surface antigen in influenza viruses from human and avian sources. J Gen Virol. 1968 Sep;3(2):201–208. doi: 10.1099/0022-1317-3-2-201. [DOI] [PubMed] [Google Scholar]